Paclitaxel-eluting versus bare-metal stents in acute ST elevation myocardial infarction (STEMI)

Critical Pathways in Cardiology

Volumn 7, Issue 4, 2008, Pages 232-238

  Hamirani, Yasmin S ^a,d   Jibrin, Ismaila ^b   Abraham, Daniel ^a   Merriman, Barry ^c   Wenz, Charlene ^a   Bahr, Raymond D ^a  

^a ST AGNES HOSPITAL   (United States)

^b GRIFFIN HOSPITAL   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d NONE   (United States)

Author keywords

Acute ST elevation myocardial infarction; Bare metal stent; Paclitaxel eluting stent; Primary angioplasty

Indexed keywords

'TAXUS'; GLYCERYL TRINITRATE; PACLITAXEL; UNCLASSIFIED DRUG; METAL;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BARE METAL STENT; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ELUTING STENT; DRUG SAFETY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART DEATH; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; RESTENOSIS; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION; STATISTICS; TREATMENT OUTCOME; AGED; ANGIOCARDIOGRAPHY; CLINICAL PATHWAY; COHORT ANALYSIS; ELECTROCARDIOGRAPHY; HEART INFARCTION; HOSPITALIZATION; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NONPARAMETRIC TEST; PROBABILITY; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; STANDARD; STENT; SURVIVAL RATE; TRANSLUMINAL CORONARY ANGIOPLASTY;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COHORT STUDIES; CORONARY ANGIOGRAPHY; CRITICAL PATHWAYS; DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; METALS; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PACLITAXEL; PROBABILITY; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; STENTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 58249088484     PISSN: 1535282X     EISSN: 15352811     Source Type: Journal    
DOI: 10.1097/HPC.0b013e3181805e0b     Document Type: Article

References (30)

1. Erbel R, Haude M, Hopp H, et al. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. N Engl J Med. 1998;339:1672-1678.
2. Holmes DR Jr, Vlietstra RE, Smith HC, et al. Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. Am J Cardiol. 1984;53:77C-81C.
3. Weintraub WS, Boccuzzi SJ, Klein JL, et al. Lack of effect of lovastatin on restenosis after coronary angioplasty. NEngl JMed. 1994;331:1331-1337.
4. Nobuyoshi M, Kimura T, Nosaka H, et al. Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic followup of 229 patients. JAm Coll Cardiol. 1988;12:616-623.
5. Serruys PW, Unger F, Sousa JE. Comparison of coronary artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001;344:1117-1124.
6. Anonymous. Drug-eluting stents. Med Lett. 2003;45:23-24.
7. Sousa JE, Serruys PW, Costa MA. New frontiers in cardiology. Drug- eluting stents: part I. Circulation. 2003;107:2274-2279.
8. Curfman GD. Sirolimus-eluting coronary stents. N Engl J Med. 2002; 346:1770-1771.
9. Giola G, Matthal W, Benassi A, et al. Improved survival with drug- eluting stent implantation in comparison with bare metal stent in patients with severe left ventricular dysfunction. Catheter Cardiovasc Interv. 2006;68:392-398.
10. Nordmann AJ, Hengstler P, Harr T, et al. Clinical outcomes of primary stenting versus balloon angioplasty in patients with myocardial infarction: a meta-analysis of randomized controlled trials. Am J Med. 2004; 116:253-262.
11. Zhu MM, Feit A, Chadow H, et al. Primary stent implantation compared with primary balloon angioplasty for acute myocardial infarction: a met-analysis of randomized clinical trials. Am JCardiol. 2001;88:297-301.
12. Saia F, Lemos PA, Lee CH, et al. Sirolimus eluting stent implantation in ST-elevation acute myocardial infarction: a clinical and angiographic study. Circulation. 2003;108:1927-1929.
13. Lee CH, Lim J, Low A, et al. Sirolimus-eluting, bioabsorbable polymer- coated constant stent (Cura) in acute ST-elevation myocardial infarction: a clinical and angiographic study (CURAMI Registry). J Invasive Cardiol. 2007;19:182-185.
14. Percoco G, Manari A, Guastaroba P, et al. Related articles, safety and long-term efficacy of sirolimus eluting stent in ST-elevation acute myocardial infarction: the REAL (Registro REgionale AngiopLastiche Emilia-Romagna) registry. Cardiovasc Drugs Ther. 2006;20:63-68.
15. Zeymer U, Zahn R, Hochadel M, et al. Indications and complications of invasive diagnostic procedures and percutaneous coronary interventions in the year 2003. Results of the quality control registry of the Arbeits- gemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Z Kardiol. 2005;94:392-398.
16. Novaro GM, Cherla A, Fromkin KR, et al. Drug-eluting stent implantation in ST-elevation acute myocardial infarction: 'real world' 30-day and mid-term results. Cardiovasc Revasc Med. 2007;8:5-8.
17. Laarman GJ, Suttorp MJ, Dirksen MT, et al. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med. 2006;355:1105-1113.
18. Chechi T, Vittori G, Biondi Zoccai GG, et al. Single-center randomized evaluation of paclitaxel-eluting versus conventional stent in acute myo- cardial infarction (SELECTION). JInterv Cardiol. 2007;20:282-291.
19. Aversano T, Aversano LT, Passamani E, et al. Atlantic Cardiovascular Patient Outcomes Research Team (C-PORT). Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial. JAMA. 2002;287:1943-1951. Erratum in: JAMA. 2002;287:3212.
20. Spaulding C, Henry P, Teiger E, et al. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med. 2006;355:1093-1104.
21. Valgimigli M, Percoco G, Malagutti P, et al. Tirofiban and sirolimus- eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. JAMA. 2005;293:2109-2117.
22. Gao H, Yan HB, Zhu XL, et al. Firebird sirolimus eluting stent versus bare mental stent in patients with ST-segment elevation myocardial infarction. Chin Med J (Engl). 2007;120:863-867.
23. Menichelli M, Parma A, Pucci E, et al. Randomized trial of Sirolimus- Eluting Stent Versus Bare-Metal Stent in Acute Myocardial Infarction (SESAMI). J Am Coll Cardiol. 2007;49:1924-1930.
24. Newell MC, Henry CR, Unger BT, et al. Comparison of safety and efficacy of sirolimus-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction. Am J Cardiol. 2006; 97:1299-1302.
25. Cheneau E, Rha SW, Kuchulakanti PK, et al. Impact of sirolimus-eluting stents on outcomes of patients treated for acute myocardial infarction by primary angioplasty, Catheter Cardiovasc Interv. 2005;65:469-472.
26. Lemos PA, Saia F, Hofma SH, et al. Short- and long-term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction. J Am Coll Cardiol. 2004;43:704-708.
27. Kastrati A, Dibra A, Spaulding C, et al. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J. 2007;28:2706-2713.
28. Lemos PA, Serruys PW, van Domburg RT, et al. Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world"; the Rapamycin-Eluting Stent Evaluated At Rotterdan Cardiology Hospital (RESEARCH) registry. Circulation. 2004;109:190-195.
29. Hofma SH, Ong AT, Aoki J, et al. One year clinical follow up of paclitaxel eluting stents for acute myocardial infarction compared with sirolimus eluting stents. Heart. 2005;91:1176-1180.
30. Galløe AM, Thuesen L, Kelbæk H, et al. Comparison of paclitaxel- and sirolimus-eluting stents in everyday clinical practice: the SORT OUT II randomized trial. JAMA. 2008;299:409-416.